Featured Suppliers:

Complete school directory of US
Pharmaceutical training programs

Sponsored Links


 
 

Higher Dose of Merck's COZAAR® (losartan potassium tablets) Significantly Reduced Deaths and Hospitalizations Due to Heart Failure In Investigational Study (Business Wire)

News  |  finance.yahoo.com | Nov 17, 2009

ORLANDO, Fla.--(BUSINESS WIRE)--In an investigational study, Merck's medicine COZAAR (losartan potassium tablets) 150 mg, administered once daily, significantly reduced

http://finance.yahoo.com/news/Higher-Dose-of-Mercks-COZAAR-bw-1721053602.html?x=0&.v=1

AAPS Announces Annual Awards, Names 2009 Fellows

News  |  pharmtech.findpharma.com | Nov 12, 2009

The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week.

http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?ref=25

Healthcare Sector Accounts for 8% of U.S. Carbon Footprint · Environmental Leader · Green Business,

News  |  www.environmentalleader.com | Nov 11, 2009

The U.S. healthcare sector accounts for nearly a tenth of the country's carbon-dioxide emissions, according to University of Chicago researchers. The research takes into account activities such as hospital care, scientific research and the production and distribution of pharmaceutical drugs.

http://www.environmentalleader.com/2009/11/11/healthcare-sector-accounts-for-8-of-u-s-carbon-footprint/

Particle Sciences Acquires Additional Space for Operations

Press Release  |  www.prnewswire.com | Nov 10, 2009

Particle Sciences Inc., a leading pharmaceutical CRO, has further expanded their capabilities by the acquisition of additional space bringing their total to approximately 21,000 sq ft. "Our current workload and existing pipeline simply necessitates this addition," says Dr. Mark Mitchnick, CEO.

http://www.prnewswire.com/news-releases/particle-sciences-acquires-additional-space-for-operations-69668927.html

 

Researchers show how PCBs may alter in utero, neonatal brain development

News  |  www.news-medical.net | Apr 14, 2009

In three new studies - including one appearing online in the Public Library of Science - Biology (PLoS - Biology) - UC Davis researchers provide compelling evidence of how low levels of polychlorinated biphenyls (PCBs) alter the way brain cells develop. In three new studies - including one

http://www.news-medical.net/?id=48278

Isis Scientist Awarded 2009 Ebert Prize

Press Release  |  news.prnewswire.com | Apr 6, 2009

. "Our work demonstrated, for the first time, that antisense drugs could be administered orally. The feasibility of oral administration has dramatically broadened the therapeutic and commercial potential of antisense drugs."

http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/04-06-2009/0005001303&EDATE=

Irish Medical Times | News | TCD showcases bioscience

News  |  www.imt.ie

TCD's academic research endeavours that offer significant commercial, economic and societal value. The event aims to highlight cutting edge technologies that have reached the commercialisation stage and offer industry collaboration and investment opportunities.

http://www.imt.ie/news/2009/03/tcd_showcases_bioscience.html

The New Millennium

News  |  www.dddmag.com

The acquisition of Millennium Pharmaceuticals by Takeda Pharmaceutical Company has fattened the pipelines. But can the current staff handle the new load?

http://www.dddmag.com/article-Millennium-Takeda-Oncology-Proflie.aspx

 

Results 1-10 of 211

Refine by Content Type:

  • Refined by: News  

Refine by Source:

Choose a source :

Close

91 Sources ...

Refine by Company:

Choose a company :

Close

58 Companies ...